We had hypothesized that CD137 would also enhance proliferation of B cell lines, especially since CD137 can be expressed as a neoantigen by certain B cell lymphomas (our unpublished data). Here, TNFRSF9 is linked to B-cell non-Hodgkin lymphoma.